In addition, therapeutic approaches aimed at disrupting key regulatory interactions, including those involving TAF1, MYC, MAZ, and other TFs such as KLF15 and ZNF281, may suppress tumor growth and modulate stress adaptation, thereby enabling more precise interventions against cancer. This evidence concerns the gene MAZ and neoplasm.